Fundraising Fox

Exit 156 CapitalFull Portfolio

6 tracked investments · listed companies and verified rows first

Blue Wolf Transformationsbluewolfbody.com

Blue Wolf Body Sculpting is a cosmetic body-contouring provider offering liposuction, awake liposuction, belly fat removal, and body contouring services to individuals seeking fat reduction.

HealthtechWellness & FitnessMidwest, US

Humla Healthhumla.comin

Humla Health operates a staffing platform that connects W-2 nurses directly with health care facilities for per diem shifts and long-term assignments, letting nurses set their own schedules and minimum pay rates.

Future of WorkHealthtechHR TechMarketplacesSaaS

NightWarenightware.cominApr 2026

NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD.

Digital HealthHealthtechMedical DevicesMental HealthHopkins, US

Matthew Tucker(Executive Officer, Director)inGrady Hannah(Director)Michael Nathan(Executive Officer, Director)

BoardMichael Ott(Director)Gerald Mattys(Director)

UrgentIQurgentiq.cominMay 2023

UrgentIQ provides an AI-native electronic medical record and practice management system designed specifically for urgent care centers, handling patient intake, clinical documentation, coding, and billing.

Digital HealthHealthtechSaaSNew York, US

Nathaniel Gibbs(Executive Officer, Director, Promoter)inEric Slater(Executive Officer, Director, Promoter)

Vail Scientificvailscientific.comin

Vail Scientific develops VSNO, a non-invasive, point-of-care diagnostic tool for rapid screening of patients suspected of having sepsis to aid in triage.

BiotechDeep TechDigital HealthHealthtechMedical DevicesMinneapolis, US

Tom Burke(CEO)in

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

CLO-CLO Foods

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.